Literature DB >> 11300605

Plasma cholesteryl ester transfer and hepatic lipase activity are related to high-density lipoprotein cholesterol in association with insulin resistance in type 2 diabetic and non-diabetic subjects.

S C Riemens1, A van Tol, L M Scheek, R P Dullaart.   

Abstract

We evaluated the hypothesis that plasma cholesteryl ester transfer (CET) and lipase activities are influenced by insulin sensitivity and contribute to the low high-density lipoprotein (HDL) cholesterol observed in type 2 diabetic patients and insulin-resistant non-diabetic subjects. Sixteen type 2 diabetic and 16 non-diabetic subjects participated. Diabetic and non-diabetic subjects were divided in equal groups of eight subjects with low or high insulin sensitivity, which was documented as the glucose infusion rate (M-value) during the last hour of a 3-h euglycaemic hyperinsulinaemic clamp (150 mU kg(-1) h(-1), blood glucose target 4.6 mmol L(-1)). Post-heparin plasma lipoprotein lipase (LPL) and hepatic lipase (HL) activities were measured in samples obtained 1-2 weeks before the clamp. Plasma CET was measured by a radioisotope method. Compared to non-diabetic men with high insulin sensitivity (n = 8) HDL cholesterol was lower in type 2 diabetic men (n=8, p<0.01) and non-diabetic men (n=8, p <0.05) with low insulin sensitivity, and the HDL cholesterylester content was lower in type 2 diabetic men with high insulin sensitivity (n=8, p<0.05). In non-diabetic subjects with high insulin sensitivity, plasma CET was lower than in the other groups (p<0.05 for all). Multiple regression analysis showed that plasma CET (p=0.001) and HL activity (p=0.02) were independently and negatively associated with the M-value. No association between the M-value and LPL activity was observed. Independent negative relationships of HDL cholesterol with plasma CET (p = 0.04) and HL activity (p=0.03) were observed. This study supports the hypothesis that a low HDL cholesterol associated with insulin resistance in type 2 diabetic and non-diabetic subjects is related to a high plasma CET and a high HL activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11300605     DOI: 10.1080/00365510151067866

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  5 in total

1.  Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the Framingham Heart Study.

Authors:  Sander J Robins; Asya Lyass; Justin P Zachariah; Joseph M Massaro; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-10       Impact factor: 8.311

2.  Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects.

Authors:  Camila C Leança; Valéria S Nunes; Natália B Panzoldo; Vanessa S Zago; Eliane S Parra; Patrícia M Cazita; Matti Jauhiainen; Marisa Passarelli; Edna R Nakandakare; Eliana C de Faria; Eder C R Quintão
Journal:  Cardiovasc Diabetol       Date:  2013-11-22       Impact factor: 9.951

3.  Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.

Authors:  Shuang Liang; Yanyan Hu; Caihong Liu; Jianhong Qi; Guimei Li
Journal:  Lipids Health Dis       Date:  2016-06-24       Impact factor: 3.876

4.  Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.

Authors:  Ruben N Eppinga; Minke H T Hartman; Dirk J van Veldhuisen; Chris P H Lexis; Margery A Connelly; Erik Lipsic; Iwan C C van der Horst; Pim van der Harst; Robin P F Dullaart
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

5.  Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes Mellitus.

Authors:  Bárbara Yasmin Gueuvoghlanian-Silva; Fernanda Bertuccez Cordeiro; Thalita Frutuoso Lobo; Thaís Regiani Cataldi; Edson Guimarães Lo Turco; Ricardo Pimenta Bertolla; Rosiane Mattar; Maria Regina Torloni; Silvia Daher
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.